RE:RE:RE:RE:RE:RE:RE:RE:Deals are abound!!!!Buckhenry wrote:
The thing here is Matt has poured his life into this and I dont think he is going to sell at this time. if the revenue projections are correct they would see close to 5B in 2025. if that is even close I would not sell the company for anything less than 50B if I were him. the one issue is.... can he hold out until he gets that revenue stream. the stock price would obviously go up dramatically if that were to occur. I think matt wants to be another Pfizer... not sell to Pfizer. thoughts??
Don’t know but if the product prove to be effective in all studies that are going on, how can we prevent a cheap buyout. Of course, if results continue to be good the SP will follow and will be in a better shape. I’m concern about an hostile and cheap buyout.